“…Better QOL among patients with advanced NSCLC under chemotherapy has been consistently associated with younger age (Henoch, Bergman, Gustafsson, Gaston-Johansson, & Danielson, 2007;Liu et al, 2009); better economic status (Liu et al, 2009;Pan, Xu, Wang, & Zhu, 2011); being employed (Hermann & Looney, 2011); stronger social support (Liang, Jiang, & Li, 2007;Luszczynska, Pawlowska, Cieslak, Knoll, & Scholz, 2013); better performance status (Henoch et al, 2007;Hermann & Looney, 2011;Iyer, Taylor-Stokes, & Roughley, 2013); better treatment response to chemotherapy (Liu et al, 2009;Zhan, 2008); less frequent, severe, and distressing physical symptoms (Hermann & Looney, 2011); and less anxiety and depressive symptoms (Chen, Yu, & Yang, 2008;Hermann & Looney, 2011;Iyer et al, 2013).…”